A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting: R-EFECT study

BACKGROUND: Several clinical trials in chronic phase (CP) chronic myeloid leukemia (CML) showed that early response to tyrosine kinase inhibitor (TKI) treatment results in an improved long-term survival and progression-free survival. This study assessed whether patients achieving early treatment res...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Wien Klin Wochenschr
Autores principales: Petzer, Andreas L., Sperr, Wolfgang R., Buxhofer-Ausch, Veronika, Sliwa, Thamer, Schmidt, Stefan, Greil, Richard, Wölfler, Albert, Pichler, Petra, Dormann, Clemens, Burgstaller, Sonja, Tinchon, Christoph, Lang, Alois, Goebel, Florian, Uthman, Shanow, Muenchmeier, Niklas, Valent, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Vienna 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445202/
https://ncbi.nlm.nih.gov/pubmed/32533444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-020-01690-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares